These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. Ressler KJ, Rothbaum BO, Tannenbaum L, Anderson P, Graap K, Zimand E, Hodges L, Davis M. Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361 [Abstract] [Full Text] [Related]
4. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Norberg MM, Krystal JH, Tolin DF. Biol Psychiatry; 2008 Jun 15; 63(12):1118-26. PubMed ID: 18313643 [Abstract] [Full Text] [Related]
8. Integrating research on development and fear learning: a vision for clinical neuroscience? Pine DS. Depress Anxiety; 2009 Jun 15; 26(9):775-9. PubMed ID: 19731230 [No Abstract] [Full Text] [Related]
11. Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications. Richardson R, Ledgerwood L, Cranney J. Learn Mem; 2004 Jun 15; 11(5):510-6. PubMed ID: 15466301 [Abstract] [Full Text] [Related]
12. NMDA receptors and fear extinction: implications for cognitive behavioral therapy. Davis M. Dialogues Clin Neurosci; 2011 Jun 15; 13(4):463-74. PubMed ID: 22275851 [Abstract] [Full Text] [Related]
13. Role of GABA in memory and anxiety. Kalueff A, Nutt DJ. Depress Anxiety; 2011 Jun 15; 4(3):100-10. PubMed ID: 9166638 [Abstract] [Full Text] [Related]
14. Augmentation of cognitive behavioral therapy with pharmacotherapy. Ganasen KA, Ipser JC, Stein DJ. Psychiatr Clin North Am; 2010 Sep 15; 33(3):687-99. PubMed ID: 20599140 [Abstract] [Full Text] [Related]
15. First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives. Arch JJ, Craske MG. Psychiatr Clin North Am; 2009 Sep 15; 32(3):525-47. PubMed ID: 19716989 [Abstract] [Full Text] [Related]